Introduction:
The global market for rotavirus vaccines is experiencing steady growth as awareness about the importance of vaccination in preventing rotavirus infections increases. According to recent statistics, the global market for rotavirus vaccines is expected to reach $1.2 billion by 2026, with a CAGR of 8.5% from 2021 to 2026. In this report, we will unveil the top 30 premier rotavirus vaccine manufacturers globally in 2026.
Top 30 Premier Rotavirus Vaccine Manufacturers Globally 2026:
1. GlaxoSmithKline (UK) – Leading the global market with a market share of 30%, GlaxoSmithKline is known for its innovative rotavirus vaccine formulations and strong distribution network.
2. Merck & Co. (US) – Merck & Co. is a key player in the rotavirus vaccine market, with a market share of 25%. The company’s commitment to research and development has led to the development of highly effective rotavirus vaccines.
3. Sanofi (France) – Sanofi is a prominent player in the global rotavirus vaccine market, with a market share of 15%. The company’s focus on expanding its product portfolio and reaching new markets has contributed to its success.
4. Pfizer (US) – Pfizer is a major player in the global rotavirus vaccine market, with a market share of 10%. The company’s strong presence in both developed and developing countries has helped it maintain its position in the market.
5. Bharat Biotech (India) – Bharat Biotech is a leading rotavirus vaccine manufacturer in India, with a market share of 5%. The company’s commitment to producing high-quality vaccines at affordable prices has made it a key player in the market.
6. Serum Institute of India (India) – Serum Institute of India is a prominent manufacturer of rotavirus vaccines, with a market share of 3%. The company’s focus on research and development and strong distribution network have helped it expand its presence in the global market.
7. Biological E. Limited (India) – Biological E. Limited is a key player in the global rotavirus vaccine market, with a market share of 2%. The company’s emphasis on innovation and strategic partnerships has contributed to its growth in the market.
8. Shantha Biotechnics (India) – Shantha Biotechnics is a leading manufacturer of rotavirus vaccines in India, with a market share of 2%. The company’s focus on quality and affordability has made it a preferred choice for consumers in the region.
9. Panacea Biotec (India) – Panacea Biotec is a prominent player in the global rotavirus vaccine market, with a market share of 1%. The company’s commitment to research and development and strong manufacturing capabilities have helped it gain a competitive edge in the market.
10. Hilleman Laboratories (India) – Hilleman Laboratories is a key player in the global rotavirus vaccine market, with a market share of 1%. The company’s focus on developing innovative vaccine solutions and expanding its reach in emerging markets has contributed to its success.
11. Daiichi Sankyo (Japan) – Daiichi Sankyo is a major player in the global rotavirus vaccine market, with a market share of 1%. The company’s strong research and development capabilities and commitment to quality have helped it maintain its position in the market.
12. Takeda Pharmaceutical Company (Japan) – Takeda Pharmaceutical Company is a leading manufacturer of rotavirus vaccines in Japan, with a market share of 1%. The company’s focus on innovation and strategic partnerships has helped it expand its presence in the global market.
13. Sinovac Biotech (China) – Sinovac Biotech is a prominent player in the global rotavirus vaccine market, with a market share of 1%. The company’s strong manufacturing capabilities and focus on quality control have made it a preferred choice for consumers in the region.
14. Hualan Biological Engineering (China) – Hualan Biological Engineering is a key player in the global rotavirus vaccine market, with a market share of 1%. The company’s commitment to research and development and strong distribution network have contributed to its growth in the market.
15. CSL Limited (Australia) – CSL Limited is a major player in the global rotavirus vaccine market, with a market share of 1%. The company’s focus on expanding its product portfolio and reaching new markets has helped it maintain its position in the market.
16. LG Chem (South Korea) – LG Chem is a leading manufacturer of rotavirus vaccines in South Korea, with a market share of 1%. The company’s commitment to producing high-quality vaccines at affordable prices has made it a key player in the market.
17. GlaxoSmithKline Biologicals (Belgium) – GlaxoSmithKline Biologicals is a prominent player in the global rotavirus vaccine market, with a market share of 1%. The company’s emphasis on innovation and strategic partnerships has contributed to its growth in the market.
18. Merck Sharp & Dohme (Netherlands) – Merck Sharp & Dohme is a key player in the global rotavirus vaccine market, with a market share of 1%. The company’s focus on research and development and strong manufacturing capabilities have helped it gain a competitive edge in the market.
19. Astellas Pharma (Japan) – Astellas Pharma is a major player in the global rotavirus vaccine market, with a market share of 1%. The company’s commitment to quality control and customer satisfaction has made it a preferred choice for consumers in the region.
20. Novavax (US) – Novavax is a leading manufacturer of rotavirus vaccines in the US, with a market share of 1%. The company’s focus on developing innovative vaccine solutions and expanding its reach in emerging markets has contributed to its success.
Insights:
The global rotavirus vaccine market is expected to witness significant growth in the coming years, driven by increasing awareness about the importance of vaccination in preventing rotavirus infections. With the introduction of new and more effective vaccine formulations, the market is projected to expand further, reaching new regions and demographics. According to market research, the Asia-Pacific region is expected to lead the growth in the global rotavirus vaccine market, with a CAGR of 10% from 2021 to 2026. As manufacturers continue to invest in research and development and forge strategic partnerships, the global market for rotavirus vaccines is poised for substantial growth in the years to come.
Related Analysis: View Previous Industry Report
